🇺🇸 FDA

Company profile · Sponsor

Transcode

Transcode Therapeutics

RNAZ · NYSE pharma BOSTON, MA, USA
Pipeline
2
Drugs
0
Patents
0

Quick answer

Transcode (RNAZ) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker RNAZ
Exchange NYSE
Company type pharma
Headquarters BOSTON, MA, USA
SEC CIK 0001829635

Pipeline (2)

Search pipeline →

  1. TTX-MC138

    Transcode

    Advanced Solid Tumor

    phase 2 small molecule active

    1 trial

  2. TTX-MC138-NODAGA-Cu64

    Transcode

    Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is Transcode?

Transcode (RNAZ) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Transcode sponsor?

We track 2 ClinicalTrials.gov-linked programs for Transcode, including TTX-MC138 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Transcode company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.